Robin Cooke Vance Partner

Save current page as PDF

Robin handles international intellectual property and technology development, protection, enforcement, licensing, and commercialization matters for clients in the entertainment, energy, biotechnology, consumer products, and retail industries. She manages worldwide intellectual property portfolios for a variety of clients, including those having famous trademark rights, and regularly advises on IP transactions and securitizations.

Robin has extensive experience with software and other technology licensing and development agreements and related transactions, domain name management and dispute resolution, e-commerce issues, data analytics, advertising law, trademark law and copyright matters. Robin’s licensing experience includes both for-profit and non-profit parties as well as universities and other educational institutions covering a wide array of goods and services found in numerous industries such as energy, medical device/pharmaceutical development, consumer goods and services, food and beverage products, music and entertainment and data analysis offerings.

Prior to joining McGuireWoods, Robin was an attorney at Studio Ubertazzi in Milan, Italy. In 1997, she studied International Law and Economics of the European Union at Cambridge University.


  • Representation of global lifestyle and sporting goods company, managing the worldwide intellectual property portfolios and licensing programs.
  • Representation of a North American retailer of energy and energy services and its parent company in the $60 million acquisition of an Israeli energy management firm, which provides technology to help lower energy consumption, reduce operating costs and increase overall operational efficiency
  • Representation of global sports and entertainment company, managing the protection and licensing for both branded and private label offerings.
  • Representation of leading medical device and pharmaceutical company in its licensing program and related intellectual property interests, including in connection with mRNA vaccine applications.